Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · Real-Time Price · USD
2.240
+0.160 (7.69%)
At close: Dec 2, 2024, 4:00 PM
2.360
+0.120 (5.35%)
Pre-market: Dec 3, 2024, 8:22 AM EST

Lexaria Bioscience Market Cap

Lexaria Bioscience has a market cap or net worth of $39.09 million as of December 3, 2024. Its market cap has increased by 249.05% in one year.

Market Cap
39.09M
Enterprise Value
32.30M
1-Year Change
249.05%
Ranking
Category
Stock Price
$2.24

Market Cap Chart

Since February 12, 2007, Lexaria Bioscience's market cap has increased from $19.40M to $39.09M, an increase of 101.51%. That is a compound annual growth rate of 4.01%.

History

DateMarket Cap% Change
Dec 2, 202439.10M205.47%
Dec 29, 202312.80M-12.33%
Dec 30, 202214.60M-36.80%
Dec 31, 202123.10M2.67%
Dec 31, 202022.50M-24.75%
Dec 31, 201929.90M-58.30%
Dec 31, 201871.70M-38.87%
Dec 29, 2017117.30M624.07%
Dec 30, 201616.20M131.43%
Dec 31, 20157.00M125.81%
Dec 31, 20143.10M342.86%
Dec 31, 2013700.00K-12.50%
Dec 31, 2012800.00K-77.78%
Dec 30, 20113.60M-7.69%
Dec 31, 20103.90M69.57%
Dec 31, 20092.30M130.00%
Dec 31, 20081.00M-94.71%
Dec 31, 200718.90M-2.58%
View and export this data all the way back to 2007. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Anebulo Pharmaceuticals 37.34M
Lumos Pharma 37.19M
Beyond Air 37.18M
Curis 37.17M
ImmuCell 36.72M
Carisma Therapeutics 35.66M
Tonix Pharmaceuticals Holding 35.45M
BriaCell Therapeutics 35.04M
Market Cap Rankings